Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Rheumatic Heart Disease III: Medical Management

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cost-effectiveness of a multicomponent training programme for older adults with decreased functional capacity: An economic evaluation.

Experimental gerontology·2025

Same author

Cross Disciplinary Role Agreement is Needed When Coordinating Long-Term Opioid Prescribing for Cancer: a Qualitative Study.

Journal of general internal medicine·2021

Same author

Barriers to hepatitis C treatment in the era of direct-acting anti-viral agents.

Alimentary pharmacology & therapeutics·2017

Same author

Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.

Journal of viral hepatitis·2017

Same author

Palliative Care Quality Indicators for Patients with End-Stage Liver Disease Due to Cirrhosis.

Digestive diseases and sciences·2016

Same author

Disclosing large scale adverse events in the US Veterans Health Administration: lessons from media responses.

Public health·2016

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

The hepatitis C self-management programme: a randomized controlled trial.

E J Groessl¹, K R Weingart, C J Stepnowsky

¹VA San Diego Healthcare System, CA, USA. egroessl@ucsd.edu

Journal of Viral Hepatitis

|June 10, 2010

Summary

This summary is machine-generated.

A self-management workshop improved hepatitis C (HCV) knowledge and quality of life in a disadvantaged population. This intervention enhances health outcomes for individuals with chronic hepatitis C, regardless of antiviral therapy.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Related Experiment Videos

Last Updated: Jun 12, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

A Protocol for Analyzing Hepatitis C Virus Replication

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Area of Science:

Hepatology
Public Health
Behavioral Science

Background:

Chronic hepatitis C (HCV) affects millions globally, with many patients unable to access or unwilling to undergo antiviral treatment.
Behavioral education, including alcohol avoidance and symptom management, is crucial, especially for disadvantaged populations with high liver risk factors.
Self-management interventions offer a promising avenue to enhance HCV knowledge and health-related quality of life (HRQOL).

Purpose of the Study:

To evaluate the efficacy of a 6-week self-management workshop compared to an information-only intervention for patients with chronic hepatitis C.
To assess the impact of the intervention on HCV knowledge, self-efficacy, HRQOL, depression, energy, and health distress.

Main Methods:

132 patients with HCV from a disadvantaged background were randomized into two groups: a 6-week self-management workshop or an information-only control.
The workshop utilized cognitive-behavioral principles, adapted from existing chronic disease programs with added HCV-specific modules.
Outcomes were measured at baseline and 6 weeks using validated instruments assessing HRQOL, knowledge, self-efficacy, and distress.

Main Results:

Participants in the self-management workshop showed significant improvements in HCV knowledge (P < 0.001) and HCV self-efficacy (P = 0.011) compared to the control group.
A notable increase in SF-36 energy/vitality scores was observed in the workshop group (P = 0.040).
Trends towards improvement were also seen in SF-36 physical functioning and health distress.

Conclusions:

The 6-week self-management program effectively improved disease knowledge and HRQOL in a disadvantaged population with hepatitis C.
This intervention demonstrates potential to enhance the health of individuals with chronic hepatitis C, independent of antiviral treatment.
Further research is warranted to explore long-term outcomes, impact on antiviral treatment adherence, and cost-effectiveness.